This image of a healthcare professional was generated using artificial intelligence.

Welcome to Madrigal Connect: Madrigal’s portal for UK healthcare professionals. 

A dedicated hub providing key information on metabolic dysfunction-associated steatohepatitis (MASH), useful educational resources to support clinical practice, and news about upcoming events. 

Image of fibrotic liver from MASH progression leavepiece.

What is MASH?

MASH is a rapidly growing public health concern 
in the UK, with a prevalence of approximately 5%.1

It is often clinically silent allowing undetected disease progression.2,3

Worsening fibrosis increases the risk of complications and mortality, emphasising the need for timely intervention.4-6

Congress information

Event details and useful resources from key congresses in the MASH community.

Diabetes UK Professional Conference

22–24 April, 2026

Liverpool, UK

BSG LIVE ’26

22–25 June, 2026

Liverpool, UK

Stay up-to-date with Madrigal Connect

Don’t miss any updates by registering your details.

Resources for healthcare professionals

These resources aim to improve understanding of MASH and support clinical practice.

MASH disease progression overview

This is a summary of the natural history of MASH, which reviews the key characteristics and epidemiology of different disease stages.

Risk stratification algorithm for patients

This is a guidelines-based algorithm for the non-invasive risk stratification of patients with metabolic dysfunction-associated steatotic liver disease (MASLD), and a summary of risk-related thresholds for relevant investigations.

Visit the Madrigal UK website for corporate information, company news and additional resources.

Reference ID

Citation

Ref-01
Ref-02
Ref-03

Younossi ZM et al. Clin Gastroenterol Hepatol. 2025;S1542–3565(25)00757–8.
Luthra R, Sheth A. Adv Ther. 2025;42:1165–95.
Povsic M et al. Adv Ther. 2019;36(7):1574–94.

Ref-04
Ref-05
Ref-06

Nabi O et al. Dig Dis Sci. 2022;67(6):2584–93.
Taylor RS et al. Gastroenterology. 2020;158:1611–25.e12.
EASL, EASD, EASO. J Hepatol 2024;81:492–542.

To report an adverse event related to a Madrigal product, reporting forms and information can be found at https://yellowcard.mhra.gov.uk or search for MHRA Yellow Card in the Google Play or Apple App Store. 
Adverse events should also be reported to Madrigal on +44 800 031 8910 & [email protected].

Welcome to Madrigal Connect

This Madrigal portal is for UK healthcare professionals (HCPs) only.